Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials

Alayed Yasir; Cheung Patrick; Pang Geordi; Mamedov Alexandre; DAlimonte Laura; Deabreu Andrea; Commisso Kristina; Commisso Angela; Zhang Liang; Quon Harvey C.; Musunuru Hima Bindu; Helou Joelle; Loblaw D. Andrew

首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials

【24h】

Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials

机译：用于前列腺型烧蚀放疗（SABR）的剂量升级：来自两项前瞻性临床试验的晚期结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: Optimal prostate SABR dose-fractionation is unknown. This study compares long-term outcomes from two prospective trials.

机译：目的：最佳前列腺SABR剂量分级未知。本研究比较了两项前瞻性试验中的长期结果。

著录项

来源
《Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology》 |2018年第2期|共6页
作者
Alayed Yasir; Cheung Patrick; Pang Geordi; Mamedov Alexandre; DAlimonte Laura; Deabreu Andrea; Commisso Kristina; Commisso Angela; Zhang Liang; Quon Harvey C.; Musunuru Hima Bindu; Helou Joelle; Loblaw D. Andrew;
展开▼
作者单位

Sunnybrook Hlth Sci Ctr Dept Radiat Oncol Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Dept Radiat Oncol Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Dept Radiat Oncol Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Dept Radiat Oncol Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Dept Radiat Oncol Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Dept Radiat Oncol Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Dept Radiat Oncol Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Dept Radiat Oncol Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Dept Radiat Oncol Odette Canc Ctr Toronto ON Canada;

Tom Baker Canc Inst Calgary AB Canada;

Univ Wisconsin Dept Human Oncol Madison WI 53706 USA;

Sunnybrook Hlth Sci Ctr Dept Radiat Oncol Odette Canc Ctr Toronto ON Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Prostate cancer; Stereotactic body radiotherapy; PSA; Dose-escalation;

机译：前列腺癌;立体定位体放射疗法;PSA;剂量 - 升级;

相似文献

外文文献
中文文献
专利

1. 中晚期鼻咽癌新辅助化疗联合放疗前瞻性临床试验的长期结果 [J] . 马骏, 麦海强, 洪明晃, 癌症（英文版） . 2001,第005期
2. Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials [J] . Alayed Yasir, Cheung Patrick, Pang Geordi, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2018,第2期

机译：用于前列腺型烧蚀放疗（SABR）的剂量升级：来自两项前瞻性临床试验的晚期结果
3. A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma [J] . Rohann J. M. Correa, Belal Ahmad, Andrew Warner, Radiation oncology . 2018,第1期

机译：立体定向消融放疗（SABR）替代细胞减少性肾切除术的I期前瞻性剂量递增试验，用于无法手术的转移性肾细胞癌患者
4. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity [J] . Christy Goldsmith, P. Nicholas Plowman, Melanie M. Green, Radiation oncology . 2018,第1期

机译：立体定向消融放疗（SABR）作为胰腺癌的主要，辅助，巩固和再治疗选择：剂量递增的范围和毒性课程
5. Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR) [C] . S Devpura, M S Siddiqui, D Chen, ICCR . 2014

机译：肺癌治疗计划剂量计算的建议（SABR）治疗肺癌治疗计划（SABR）
6. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
7. A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma [O] . Rohann J. M. Correa, Belal Ahmad, Andrew Warner, 2018

机译：立体定向消融放疗（SABR）的前瞻性I阶段剂量递增试验用于无法手术的转移性肾细胞癌患者的细胞减少性肾切除术
8. Phase I Dose-Escalation Trial of Stereotactic Ablative Body Radiotherapy (SAbR) for Men with High-Risk Prostate Cancer [O] . S. Salamekh, N.B. Desai, M.R. Folkert, 2020

机译：I期IOSE-升级试验的立体定向烧蚀身体放射治疗（SABR）具有高危前列腺癌的男性
9. EF5 PET of Tumor Hypoxia: A Predictive Imaging Biomarker of Response to Stereotactic Ablative Radiotherapy (SABR) for Early Lung Cancer. [R] . Loo, B. J. W. 2017

机译：肿瘤缺氧的EF5 pET：早期肺癌立体定向烧蚀放疗（saBR）反应的预测成像生物标志物。

Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials

摘要

著录项

相似文献

相关主题

期刊订阅